TITLE

Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance

AUTHOR(S)
Trifa, Fatma; Karray-Chouayekh, Sondes; Jmaa, Zeineb; Jmal, Emna; Khabir, Abdelmajid; Sellami-Boudawara, Tahia; Frikha, Mounir; Daoud, Jamel; Mokdad-Gargouri, Raja
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aberrant methylation of the CpG islands in promoter regions is one of the mechanisms for inactivation of tumor suppressor genes in many human cancers including breast carcinoma. In this study, we aimed to assess, by methylation-specific PCR, the CpG methylation pattern of the UCHL1 promoter in 94 sporadic and 44 hereditary breast cancers from Tunisian patients. The percentage of UCHL1 methylation was 67 % in sporadic and 82 % in hereditary breast cancer cases. In sporadic cases, UCHL1 methylation correlated with poor response to treatment ( P = 0.042) and progesterone receptor status ( P = 0.036), whereas in patients with hereditary predisposition, the only significant association was found with Her2 expression ( P = 0.024). Moreover, in patients with sporadic breast cancer, the UCHL1 unmethylated pattern conferred a prolonged overall survival time in particular in the group of patients with advanced TNM stage of the disease ( P log rank = 0.04). Aberrant CpG methylation of the UCHL1 promoter was significantly associated with transcriptional silencing of this tumor suppressor gene in sporadic breast cancer tissues ( P = 0.001). On the other hand, the UCHL1 unmethylated pattern correlated with P53 positivity in primary sporadic tumors ( P = 0.032), supporting the functional link between the two tumor suppressors in breast tumorigenesis.
ACCESSION #
85859841

 

Related Articles

  • Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Nicoll, G; Crichton, D N; McDowell, H E; Kernohan, N; Hupp, T R; Thompson, A M // British Journal of Cancer;12/15/2001, Vol. 85 Issue 12, p1878 

    A new cancer gene, HIC-1 (Hypermethylated in Cancer) telomeric top53 on chromosome 17p may be of clinical importance in sporadic breast cancer. Regional DNA hypermethylation of 17p13.3 resulting in suppression of gene expression has been shown to precede 17p structural changes in human...

  • Purging of human breast cancer cells from stem cell products with an adenovirus containing p53. Hirai, Manabu; Kelsey, Linda S; Vaillancourt, Mei; Maneval, Daniel C; Watanabe, Tsutomu; Talmadge, James E // Cancer Gene Therapy;Feb2000, Vol. 7 Issue 2, p197 

    Tumor cell contamination of stem cell products can contribute to tumor relapse following high-dose chemotherapy and stem cell rescue. Numerous techniques have been used to remove the tumor cells from stem cell products with the objective of prolonging relapse-free survival. However, to date...

  • Loss of p53-immunostaining intensity in breast cancer. Henson, Donald E. // JNCI: Journal of the National Cancer Institute;08/07/96, Vol. 88 Issue 15, p1015 

    Editorial. Comments on the impact of lost immunostaining intensity of the P53 antioncogene in treating breast cancer. Amount of immunoreactivity lost after two weeks storage on unstained glass slides; Chemicals and stain preparation procedures suspected for the lost immunostaining capacity of...

  • Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. Jacobs, Timothy W.; Prioleau, John E. // JNCI: Journal of the National Cancer Institute;08/07/96, Vol. 88 Issue 15, p1054 

    Discusses the decrease in the immunostaining properties of the P53 antioncogenes in slides of breast cancer samples. Theories linking environmental storage conditions and slide preparation chemicals to immunostaining loss; Progress of the decline in staining intensity after two weeks.

  • Heterogeneity: Cooperative crosstalk. Seton-Rogers, Sarah // Nature Reviews Cancer;Apr2015, Vol. 15 Issue 4, p198 

    The article discusses the study "Intratumoral Heterogeneity in a p53 Null Mouse Model of Human Breast Cancer" by researcher M. Zhang and colleagues and published win the journal "Cancer Discovery" which discusses factors promoting tumour growth in breast.

  • Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast. Regele, S; Kohlberger, P; Vogl, F D; Böhm, W; Kreienberg, R; Runnebaum, I B // British Journal of Cancer;10/15/99, Vol. 81 Issue 4, p702 

    Five of 43 patients (11.6%) with ductal carcinoma in situ of the breast presented with p53 autoantibodies at diagnosis. Three seropositive patients demonstrated tumour sizes of ≤ 5 mm. There was no association of p53 autoantibody status with age, clinical presentation, histological...

  • Pathology/cytology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS75 

    Presents an abstract of the research manuscript `P53, ErbB2 and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuy's System,' by R. Kanthan et al.

  • Methylation meets genomics. Feinberg, Andrew P // Nature Genetics;Jan2001, Vol. 27 Issue 1, p9 

    Studies methylome in embryonic fibroblasts to underscore the potent effect of p53 expression. Life cycle of the methylome, a neologism that describes the complete set of DNA methylation modifications of a cell; Link between alterations in the methylome with aging and cancer, as well as with...

  • P53 gene polymorphisms and breast cancer risk in Arab women. Alawadi, Shafika; Ghabreau, Lina; Alsaleh, Mervat; Abdulaziz, Zainab; Rafeek, Mohamed; Akil, Nizar; Alkhalaf, Moussa // Medical Oncology;Sep2011, Vol. 28 Issue 3, p709 

    The association between polymorphisms in the p53 tumor suppressor gene and breast cancer risk has been studied in many human populations with conflicting conclusions. However, similar studies in Arab women are not available, and the status of these polymorphisms in this ethnic population is not...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics